Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Stevanato Group S.p.A. (STVN : NYSE)

• Company Description    Stevanato Group S.p.A. is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group S.p.A. is based in PIOMBINO DESE, Italy. Number of Employees: 6,010

• Price / Volume Information    Yesterday's Closing Price: $20.51 Daily Weekly Monthly 20 Day Moving Average: 405,735 shares Shares Outstanding: 302.84 (millions) Market Capitalization: $6,211.30 (millions) Beta: 0.75 52 Week High: $28.00 52 Week Low: $12.89 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.34% 0.11% 12 Week 23.33% 20.71% Year To Date 1.94% -9.59%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL PIOMBINO DESE (PD) VIA MOLINELLA 17 - PADUA,L6 35017 ITA ph: 39049931811 fax: - lisa.miles@stevanatogroup.com http://www.stevanatogroup.com/en

• General Corporate Information    Officers Franco Stevanato - Chief Executive Officer and Chairman Sergio Stevanato - Chairman Ugo Gay - Chief Operating Officer Marco Dal Lago - Chief Financial Officer Karen Flynn - Director Peer Information Stevanato Group S.p.A. (GSAC) Stevanato Group S.p.A. (CASIF) Stevanato Group S.p.A. (ALCD.) Stevanato Group S.p.A. (OMNN) Stevanato Group S.p.A. (CGPI.) Stevanato Group S.p.A. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: T9224W109 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/05/26 Share - Related Items Shares Outstanding: 302.84 Most Recent Split Date: (:1) Beta: 0.75 Market Capitalization: $6,211.30 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.18 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.71 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 17.68% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/05/26

• Fundamental Ratios P/E Current FY Estimate: 28.89 Trailing 12 Months: 31.08 PEG Ratio: 1.63 Price Ratios Price/Book: 3.45 Price/Cash Flow: 23.25 Price / Sales: 4.35 EPS Growth vs. Year Ago Period: 33.33% vs. Previous Quarter: 23.08% Sales Growth vs. Year Ago Period: 10.51% vs. Previous Quarter: 9.66% ROE 06/30/26 - 10.43 03/31/26 - 10.27 12/31/25 - 10.44 ROA 06/30/26 - 6.16 03/31/26 - 6.08 12/31/25 - 6.22 Current Ratio 06/30/26 - 1.61 03/31/26 - 1.63 12/31/25 - 1.76 Quick Ratio 06/30/26 - 1.08 03/31/26 - 1.11 12/31/25 - 1.26 Operating Margin 06/30/26 - 12.69 03/31/26 - 12.40 12/31/25 - 12.50 Net Margin 06/30/26 - 10.99 03/31/26 - 11.76 12/31/25 - 11.83 Pre-Tax Margin 06/30/26 - 15.59 03/31/26 - 15.97 12/31/25 - 15.94 Book Value 06/30/26 - 5.95 03/31/26 - 5.92 12/31/25 - 5.55 Inventory Turnover 06/30/26 - 3.04 03/31/26 - 3.09 12/31/25 - 3.15 Debt-to-Equity 06/30/26 - 0.21 03/31/26 - 0.21 12/31/25 - 0.23 Debt-to-Capital 06/30/26 - 17.07 03/31/26 - 17.46 12/31/25 - 18.94

Powered by Zacks Investment Research ©